Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
about
Production of the islet cell antigen ICA69 (p69) with baculovirus expression system: analysis with a solid-phase time-resolved fluorescence method of sera from patients with IDDM and rheumatoid arthritisInduction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis CDo local immune-neuroendocrine disturbances initiate diabetes?Detection of autoantibodies against reactive oxygen species modified glutamic acid decarboxylase-65 in type 1 diabetes associated complicationsPrediction of type 1 diabetes in the general population.Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratoriesAdvances and challenges in biomarker development for type 1 diabetes prediction and prevention using omic technologiesDisease-associated autoantibodies as predictive markers of type 1 diabetes mellitus in siblings of affected children.Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome.Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigensHumoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus.Immunomodulation for the prevention of SPIDDM and LADA.Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes.An islet-cell protein tyrosine phosphatase is a likely precursor to the 37-kDa autoantigen in type 1 diabetes: human and macaque sequences, tissue distribution, unique and shared epitopes, and predictive autoantibodies.Biomarkers for type 1 diabetes.Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetesHoming of GAD65 specific autoimmunity and development of insulitis requires expression of both DQ8 and human GAD65 in transgenic mice.Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.Detection of GAD65 autoreactive T-cells by HLA class I tetramers in type 1 diabetic patients.Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy.The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis.Prediction of type 1 diabetes in Sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the Sardinian schoolchildren type 1 diabetes prediction study.Islet cell antigens in the prediction and prevention of insulin-dependent diabetes mellitus.Islet cell autoantigens in type 1 diabetes.Antibody screening in a population of children.Advances in childhood onset diabetes.Insulin secretion and insulin sensitivity are normal in non-diabetic subjects from maternal inheritance diabetes and deafness families.Prevalence and fate of type 1 diabetes-associated autoantibodies in cord blood samples from newborn infants of non-diabetic mothers.Islet autoantibodies in cord blood from patients who developed type 1 diabetes mellitus at 15-30 years of age.Risk assessment, prediction and prevention of type 1 diabetes.Intrafamilial spread of enterovirus infections at the clinical onset of type 1 diabetes.Prevalence of 20S proteasome, anti-nuclear and thyroid antibodies in young patients at onset of type 1 diabetes mellitus and the risk of autoimmune thyroiditis.Insulin and islet autoantibodies after pancreas transplantation.Islet cell autoantibodies: a case of a premature obituary.Antibodies to the protein tyrosine phosphatases IAR and IA-2 are associated with progression to insulin-dependent diabetes (IDDM) in first-degree relatives at-risk for IDDM.Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis.Number of islet autoantibodies present in newly diagnosed type 1 diabetes children born to non-diabetic mothers is affected by islet autoantibodies present at birth.Detection and immunochemical characterization of glutamic acid decarboxylase autoantibodies in patients with autoimmune diabetes mellitus.Flow cytometric microsphere-based immunoassay as a novel non-radiometric method for the detection of glutamic acid decarboxylase autoantibodies in type 1 diabetes mellitus.Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohort.
P2860
Q28141180-FCB86FA2-22B1-459B-B6E4-F4DB31135476Q28348712-41F4FB81-8762-4CEE-8DA3-2377F2508476Q33760236-400E80CB-5DD3-4714-A300-F68564ACD536Q33840246-12D2422F-AC11-4184-B058-3C7D7B76CE1BQ33873033-EDB857BC-D951-49FC-8173-DDB926E9D28BQ34051605-729BDE26-94CF-4BFC-8EC9-5382548FA51AQ34157932-C450EAB9-5DC4-4DDE-BA63-11C5E41D2D12Q34274380-2D2C6AEA-70FB-4CC1-9EAF-C65738246730Q35046614-92BBA8FA-158B-4D41-A5DC-38648328424FQ36111731-C95B7F84-9D78-4277-B89E-0D80A31171F4Q36318504-630F2005-51AB-481D-BCC0-B0150949D124Q36666070-5A41D560-D638-4FA3-9CE3-278506884EE3Q36796037-B3BEEA82-3F8B-4028-9040-63B325E6AE97Q36853549-E99E55CE-6660-4CEC-A88C-1DC25C010796Q37000150-4DA93E65-D796-4F52-AE86-B9FD319434E1Q37114100-924F9165-FBC2-4922-992A-566A5DE48292Q37248995-8D18C595-69F5-4A5E-939F-26D328F258BBQ37377371-6FE127A4-F314-48CC-8C0E-1845A735671FQ37474056-F4E0CEC0-CCAD-4ACF-82EE-F9F8308C48C7Q38071010-57702424-98E3-4566-812D-C7F5297EBFC6Q38074472-2CEA4FC3-5B38-4A25-90A5-532FF87CE4F1Q39015884-3A9D7D4E-C613-4E6C-B120-D9465173595DQ40870952-FD6014CB-EEF0-4F25-94B6-10E7F7AF4953Q41205349-E6AA7BD6-01C7-4174-946E-6221636A1E4CQ41695578-E5BE44A5-5DAF-45B6-A424-0BFC89E66D70Q43102875-B85D163B-5D92-4C5B-B3B1-7B5CEEE82C7FQ43687447-A15FD248-B622-4B49-B1B4-7444C5A862B7Q43938791-5DE7F235-B89B-4792-ADE4-750022B51DB7Q44620314-54BA3E0F-7180-4B9F-B41A-C91C141C837DQ44796643-0741765F-E4E1-4B53-8078-468A4CE1597FQ44828250-AC2B1F85-E7F3-49F4-B2E0-DFDD90C3CE48Q45011194-D440B7FF-8B01-4E52-B92B-102E9BB730CFQ46810961-E67CEAEF-240C-4738-BEEF-96A057A5D2FDQ48608831-7EACFD2B-5B59-454D-8EC1-52677C59A83CQ50864565-5F61099F-4278-46D3-8029-CDE0D175AC9CQ51472839-DFE3E3D2-A684-4994-8972-257233EAB447Q51717930-F2B5A3D5-F8AE-4545-B73D-C64D0537A083Q51790735-595426E1-7362-424E-B22C-0EE1F0D07FDDQ53562750-42A2806F-DC91-4F0C-B09B-CC009B36C51BQ54959393-68F580EE-6091-4FE9-B3B4-20A3D0F71FE0
P2860
Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
@en
type
label
Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
@en
prefLabel
Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
@en
P2093
P2860
P356
P1433
P1476
Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
@en
P2093
E Bazzigaluppi
E Bognetti
E Bonifacio
G F Bottazzo
M R Pastore
P J Bingley
S Genovese
V Lampasona
P2860
P2888
P304
P356
10.1007/S001250050358
P577
1995-07-01T00:00:00Z